Biofrontera (BFRI) Institutional Ownership $0.73 +0.03 (+4.26%) (As of 11/15/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Biofrontera (NASDAQ:BFRI)CurrentInstitutional OwnershipPercentage10.08%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$776.56KNumber ofInstitutional Sellers(last 12 months)0 Get BFRI Insider Trade Alerts Want to know when executives and insiders are buying or selling Biofrontera stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BFRI Institutional Buying and Selling by Quarter Ad Genesis Gold GroupTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs. But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back…Get ahead of the game with 3 proven strategies to protect your retirement from Washington's next mov Biofrontera Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/25/2024 Rosalind Advisors Inc.504,261$777K0.7%N/A9.907% 2/10/2023 Bard Associates Inc.198,200$182K0.1%-21.7%0.742% 8/11/2022 Bard Associates Inc.259,275$482K0.2%+5.4%1.368% 5/11/2022 Bard Associates Inc.246,075$819K0.3%-28.3%1.439% 2/10/2022 Qube Research & Technologies Ltd13,700$103K0.0%N/A0.080% (Data available from 1/1/2016 forward) BFRI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BFRI shares? During the previous two years, the following institutional investors and hedge funds held shares of Biofrontera shares: Rosalind Advisors Inc. ($777K), Bard Associates Inc. ($182K).Learn more on BFRI's institutional investors. What percentage of Biofrontera stock is owned by institutional investors? 10.08% of Biofrontera stock is owned by institutional investors. Learn more on BFRI's institutional investor holdings. Which institutional investors have been buying Biofrontera stock? The following institutional investors have purchased Biofrontera stock in the last 24 months: Rosalind Advisors Inc. ($504.26K). How much institutional buying is happening at Biofrontera? Institutional investors have bought a total of 504,261 shares in the last 24 months. This purchase volume represents approximately $776.56K in transactions. Which Biofrontera major shareholders have been selling company stock? The following institutional investors have sold Biofrontera stock in the last 24 months: Bard Associates Inc. ($55.08K). How much institutional selling is happening at Biofrontera? Institutional investors have sold a total of 55,075 shares in the last 24 months. This volume of shares sold represents approximately $1.01M in transactions. Related Companies APRE Institutional Ownership NNVC Institutional Ownership FLGC Institutional Ownership UBX Institutional Ownership CYTH Institutional Ownership MEIP Institutional Ownership CGTX Institutional Ownership TNXP Institutional Ownership FNCH Institutional Ownership BGXX Institutional Ownership This page (NASDAQ:BFRI) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biofrontera Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biofrontera With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.